Purple Biotech Ltd
PPBT
$2.25
-$0.045-1.96%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -1.09M | -410.00K | -2.41M | -3.76M | |
| Total Depreciation and Amortization | 47.00K | 40.00K | 49.00K | 48.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -91.00K | -640.00K | -565.00K | -438.00K | |
| Change in Net Operating Assets | -415.00K | -1.00M | -1.06M | -930.00K | |
| Cash from Operations | -1.54M | -2.01M | -3.98M | -5.08M | |
| Capital Expenditure | -2.00K | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 109.00K | 38.00K | 87.00K | 312.00K | |
| Cash from Investing | 107.00K | 38.00K | 87.00K | 312.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -39.00K | -48.00K | -46.00K | -45.00K | |
| Issuance of Common Stock | 443.00K | 4.37M | 564.00K | 374.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -38.00K | -380.00K | -85.00K | -61.00K | |
| Cash from Financing | 366.00K | 3.94M | 433.00K | 268.00K | |
| Foreign Exchange rate Adjustments | 35.00K | 0.00 | -5.00K | -2.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -1.04M | 1.96M | -3.46M | -4.50M | |